This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 26 November - 2 December 2023 and includes updates on human infection with influenza A(H1N2)v, influenza A(H5N1), an overview of respiratory virus epidemiology in the EU/EEA, respiratory infections due to Mycoplasma pneumoniae in the EU/EEA, HIV/AIDS surveillance 2023 (2022 data), West Nile virus, SARS-CoV-2 variant classification, and poliomyelitis.
This report presents HIV/AIDS surveillance data for 2022, a year marked by increased population movements across Europe that have impacted HIV trends, particularly in EU/EEA countries.
EARS-Net is based on routine clinical antimicrobial susceptibility data from local and clinical laboratories reported to ECDC by appointed representatives from the Member States.
This report describes and summarises the results of the 2022 external quality assessment (EQA) of antimicrobial susceptibility testing (AST) by clinical laboratories that participate in the European Antimicrobial Resistance Surveillance Network (EARS-Net).
The European Centre for Disease Prevention and Control (ECDC) has previously raised the alarm on the increasing threat of antimicrobial resistance, estimating that over 35 000 people die annually from infections resistant to antibiotics in the European Union (EU), Iceland, and Norway.
This executive summary showcases results derived from 2022 antimicrobial resistance (AMR) data, sourced from invasive isolates reported to both the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) network and the European Antimicrobial Resistance Surveillance Network (EARS-Net).